Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-12-24Clinical Trial Update: Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations [Phase 2]
Phase 2 trial of PF-06649751 in Parkinson's disease patients with motor fluctuations was terminated; results posted in 2018.
-
FDA approval · 2018-12-21FDA Approved: INBRIJA — Original Application (Merz Pharmaceuticals, LLC)
The FDA approved INBRIJA (levodopa inhalation powder) under an original application from Merz Pharmaceuticals, LLC.
-
FDA approval · 2018-12-20FDA Approved: AZILECT — Supplemental Application (Teva Neuroscience, Inc.)
FDA approved a supplemental application for AZILECT (rasagiline mesylate) submitted by Teva Neuroscience, Inc.
-
CLINICAL_TRIALS trial_result · 2018-12-20Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ITI-214 in Parkinson's Disease [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating ITI-214 in Parkinson's disease assessing safety, tolerability, pharmacokinetics, and pharmac…
-
FDA approval · 2018-12-19FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approval of a generic pramipexole dihydrochloride product under an Original Application (ANDA) by Unichem Pharmaceuticals (USA), Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2018-11-29FDA Approved: NEUPRO — Supplemental Application (UCB, Inc.)
The FDA approved a supplemental application for NEUPRO (rotigotine) from UCB, Inc., resulting in updated labeling for the drug.
-
CLINICAL_TRIALS trial_result · 2018-11-29Clinical Trial Update: Methylphenidate and Parkinson's Disease [Phase 2]
Phase 2 clinical trial evaluating methylphenidate for Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2018-11-28Clinical Trial Update: Atomoxetine for Freezing of Gait in Parkinson's Disease [Phase 3]
Phase 3 clinical trial of atomoxetine for freezing of gait in Parkinson's disease has completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-11-23Clinical Trial Update: Treatment of Parkinson Disease and Multiple System Atrophy Using Intranasal Insulin. [Phase 2]
Phase 2 trial investigating intranasal insulin for Parkinson disease and multiple system atrophy has completed with results posted in 2018.
-
CLINICAL_TRIALS withdrawal · 2018-11-23Clinical Trial Update: A Study in Patients With Advanced Parkinson's Disease to Assess the Relative Bioavailability of Levodopa Administered as ND0612 Subcutaneous Infusion Versus Levodopa Administered as Carbidopa-Levodopa Enteral Suspension [Phase 3]
A Phase 3 study evaluating relative bioavailability of ND0612 subcutaneous levodopa versus enteral carbidopa-levodopa has been withdrawn.
-
CLINICAL_TRIALS research · 2018-11-19Clinical Trial Update: Exercise and Parkinson's: Comparing Interventions and Exploring Neural Mechanisms [NA]
Clinical trial update on exercise interventions for Parkinson disease, exploring neural mechanisms; study completed with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2018-11-01Clinical Trial Update: Idebenone Treatment of Early Parkinson's Diseasesymptoms [Phase 4]
A Phase 4 clinical trial update on idebenone for early Parkinson's disease focusing on oxidative stress as a contributing factor.
-
CLINICAL_TRIALS trial_result · 2018-10-23Clinical Trial Update: Efficacy Study of Light Therapy as an Adjunctive Treatment for Parkinson's Disease [NA]
Completed clinical trial evaluating light therapy as an adjunctive treatment for Parkinson's disease with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-10-19Clinical Trial Update: Long- Term Transcranial Direct Current Stimulation in Parkinson's Disease [Phase 2]
A Phase 2 clinical trial update on long-term transcranial direct current stimulation for Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2018-10-11Clinical Trial Update: Prevention of Levodopa-induced Dyskinesias by Transcranial Static Magnetic Field Stimulation (tSMS) [Phase 2]
Phase 2 clinical trial investigating transcranial static magnetic field stimulation to prevent levodopa-induced dyskinesias in Parkinson's d…
-
CLINICAL_TRIALS trial_result · 2018-10-10Clinical Trial Update: Investigating the Microstructural and Functional Alterations of Brain in Parkinson's Disease Patients [Phase 2]
Phase 2 clinical trial investigating microstructural and functional brain changes in Parkinson's disease patients has completed.
-
CLINICAL_TRIALS trial_result · 2018-10-09Clinical Trial Update: Cholinesterase Inhibitors to Slow Progression of Visual Hallucinations in Parkinson&Apos;s Disease [Phase 4]
A Phase 4 trial investigating cholinesterase inhibitors to slow progression of visual hallucinations in Parkinson's disease was terminated.
-
CLINICAL_TRIALS trial_result · 2018-10-09Clinical Trial Update: Varenicline Treatment for Excessive Daytime Sleepiness in Parkinson's Disease [Phase 4]
Phase 4 clinical trial update for varenicline in Parkinson's disease, terminated.
-
CLINICAL_TRIALS trial_result · 2018-10-05Clinical Trial Update: Evaluation of the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes [Phase 3]
Phase 3 trial evaluating [123I]NAV5001 as an imaging agent for diagnosing Parkinsonian syndromes has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-10-03Clinical Trial Update: Developing a Novel Imaging Biomarker in the Differential Diagnosis of Parkinson's Disease and Parkinsonism [Phase 2]
Phase 2 clinical trial updating development of a novel imaging biomarker to differentiate Parkinson's disease from Parkinsonism.
-
FDA approval · 2018-10-03FDA Approved: ENTACAPONE — Original Application (Lannett Company, Inc.)
FDA approved an original application for entacapone, a generic COMT inhibitor, to be used in combination with levodopa/carbidopa for Parkins…
-
CLINICAL_TRIALS trial_result · 2018-09-26Clinical Trial Update: The Cyclical Lower-extremity Exercise for Parkinson's Trial [NA]
Completed clinical trial on cyclical lower-extremity exercise for Parkinson's disease; results posted in 2018.
-
FDA approval · 2018-09-21FDA Approved: CARBIDOPA, LEVODOPA, AND ENTACAPONE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental NDA from Sandoz Inc to market a fixed-dose combination of carbidopa, levodopa, and entacapone for Parkinson's di…
-
CLINICAL_TRIALS trial_result · 2018-09-06Clinical Trial Update: GLP1R in Parkinson's Disease [Phase 2]
Phase 2 clinical trial update on GLP1R targeting therapy for Parkinson's disease is reported, status currently unknown.
-
CLINICAL_TRIALS trial_result · 2018-08-29Clinical Trial Update: GDNF in ideopathicParkinsons Disease [Phase 2]
Phase 2 clinical trial investigating GDNF for idiopathic Parkinson's disease has completed.